Study of Biomarkers in Diabetic Chronic Wounds

Launched by YIBING WANG · Apr 19, 2022

Keywords

ClinConnect Summary

This clinical trial is studying biomarkers, which are specific indicators that can help doctors understand and predict how diabetic chronic wounds heal. The goal is to find and evaluate these biomarkers to improve the diagnosis and treatment of wounds in people with diabetes. The study is currently looking for participants of all genders, aged between 18 and 75, who fall into one of three groups: healthy individuals without diabetes, diabetic individuals without new wounds, and diabetic individuals who have chronic wounds.

If you decide to join the trial, you will first need to sign a consent form, which means you agree to participate after understanding what the study involves. Participants will undergo tests to help researchers identify the biomarkers related to wound healing. However, people with severe health conditions affecting the brain, heart, lungs, liver, or kidneys, as well as those with certain other medical issues, will not be eligible to participate. This study aims to enhance the understanding of how diabetes affects wound healing, which could lead to better care for those with chronic wounds.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age between 18 and 75;
• • 2. Signed the informed consent form；
• • 3. Subjects in the ND group are the healthy participants without diabetes；
• • 4. Subjects in the NWD group are the diabetic participants without newly identified wounds；
• • 5. Subjects in the CWD group are the diabetic participants with chronic wounds
• Exclusion Criteria:
• • 1. With sever acute underlying diseases of the brain, heart, lungs, liver and/or kidney;
• • 2. No diabetes but combined with lower limb arterial stenosis, occlusion or other conditions affecting wound healing or other causes of wounds such as varicose veins in the lower limbs;
• • 3. Special exclusion criteria for blood, urine and stool samples taking.